We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Molina Healthcare Set for Q3 Earnings: Revenue Gains, But Profit Pains
Read MoreHide Full Article
Key Takeaways
Molina Healthcare is set to report Q3 2025 results on Oct. 22, after the closing bell.
Q3 EPS is estimated at $3.97, down 33.9% year over year, on revenues of $10.9 billion.
Higher costs and lower investment income cloud earnings despite premium growth.
Healthcare plan provider, Molina Healthcare, Inc. (MOH - Free Report) , is set to report third-quarter 2025 results on Oct. 22, 2025, after the closing bell. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings is currently pegged at $3.97 per shareon revenues of $10.9 billion.
The third-quarter earnings estimate remained stable over the past 60 days. The bottom-line projection indicates a year-over-year decrease of 33.9%. However, the Zacks Consensus Estimate for quarterly revenues suggests year-over-year growth of 5.4%.
Image Source: Zacks Investment Research
For full-year 2025, the Zacks Consensus Estimate for Molina Healthcare’s revenues is pegged at $44.54 billion, implying a rise of 9.6% year over year. However, the consensus mark for 2025 earnings per share is pegged at $18.87, indicating a decline of 16.7% on a year-over-year basis.
Molina Healthcare beat the consensus estimate in two of the last four quarters and missed twice, with the average surprise being negative 2.2%. This is depicted in the figure below.
Our proven model does not conclusively predict an earnings beat for the company this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy), or 3 (Hold) increases the odds of an earnings beat. That’s not the case here.
MOH has an Earnings ESP of 0.00% and carries a Zacks Rank #4 (Sell). You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
What’s Shaping MOH’s Q3 Results?
The Zacks Consensus Estimate for premiums indicates growth of 6.3% year over year in the third quarter, while our model estimate suggests a 5.3% increase. The consensus estimate for the Medicare premiums is $1.5 billion, up 8% year over year.
While Medicaid membership is expected to have decreased 2.8% year over year, MOH’s Medicare membership is projected to witness 6.5% growth. Furthermore, the Zacks Consensus Estimate for the Marketplace membership suggests a 60.8% increase from the year-ago period.
However, the consensus mark for the medical care ratio (MCR) in Marketplace is pegged at 84.67% in the to-be-reported quarter, up from 73% a year ago. The consensus mark for total MCR is pegged at 90.32%, up from 89.20% a year ago.
Along with this, rising costs and lower investment income make an earnings beat uncertain. The Zacks Consensus Estimate for investment income indicates a 15.3% decline year over year. Our model estimate for third-quarter total operating expenses suggests a more than 6% increase from the year-ago period, due to higher medical care costs and G&A expenses.
Stocks That Warrant a Look
While an earnings beat looks uncertain for Molina Healthcare, here are some companies from the broader Medical space that you may want to consider, as our model shows that these have the right combination of elements to post an earnings beat this time around:
The Zacks Consensus Estimate for Select Medical’s bottom line for the to-be-reported quarter of 18 cents per share has witnessed one upward revision against no downward movement over the past week. The consensus mark for Select Medical’s revenues is pegged at $1.32 billion.
CVS Health Corporation (CVS - Free Report) has an Earnings ESP of +0.28% and a Zacks Rank of 2.
The Zacks Consensus Estimate for CVS Health’s bottom line for the to-be-reported quarter is pegged at $1.36, signaling 24.8% growth from a year ago. CVS Health’s earnings beat estimates in each of the past four quarters, with an average surprise of 22.6%.
Envista Holdings Corporation (NVST - Free Report) has an Earnings ESP of +4.26% and a Zacks Rank of 3.
The Zacks Consensus Estimate for Envista’s bottom line for the to-be-reported quarter indicates 125% year-over-year growth. Envista’s earnings beat estimates in each of the trailing four quarters, with an average surprise of 16.5%.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Molina Healthcare Set for Q3 Earnings: Revenue Gains, But Profit Pains
Key Takeaways
Healthcare plan provider, Molina Healthcare, Inc. (MOH - Free Report) , is set to report third-quarter 2025 results on Oct. 22, 2025, after the closing bell. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings is currently pegged at $3.97 per shareon revenues of $10.9 billion.
The third-quarter earnings estimate remained stable over the past 60 days. The bottom-line projection indicates a year-over-year decrease of 33.9%. However, the Zacks Consensus Estimate for quarterly revenues suggests year-over-year growth of 5.4%.
For full-year 2025, the Zacks Consensus Estimate for Molina Healthcare’s revenues is pegged at $44.54 billion, implying a rise of 9.6% year over year. However, the consensus mark for 2025 earnings per share is pegged at $18.87, indicating a decline of 16.7% on a year-over-year basis.
Molina Healthcare beat the consensus estimate in two of the last four quarters and missed twice, with the average surprise being negative 2.2%. This is depicted in the figure below.
Molina Healthcare, Inc Price and EPS Surprise
Molina Healthcare, Inc price-eps-surprise | Molina Healthcare, Inc Quote
Q3 Earnings Whispers for MOH
Our proven model does not conclusively predict an earnings beat for the company this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy), or 3 (Hold) increases the odds of an earnings beat. That’s not the case here.
MOH has an Earnings ESP of 0.00% and carries a Zacks Rank #4 (Sell). You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
What’s Shaping MOH’s Q3 Results?
The Zacks Consensus Estimate for premiums indicates growth of 6.3% year over year in the third quarter, while our model estimate suggests a 5.3% increase. The consensus estimate for the Medicare premiums is $1.5 billion, up 8% year over year.
While Medicaid membership is expected to have decreased 2.8% year over year, MOH’s Medicare membership is projected to witness 6.5% growth. Furthermore, the Zacks Consensus Estimate for the Marketplace membership suggests a 60.8% increase from the year-ago period.
However, the consensus mark for the medical care ratio (MCR) in Marketplace is pegged at 84.67% in the to-be-reported quarter, up from 73% a year ago. The consensus mark for total MCR is pegged at 90.32%, up from 89.20% a year ago.
Along with this, rising costs and lower investment income make an earnings beat uncertain. The Zacks Consensus Estimate for investment income indicates a 15.3% decline year over year. Our model estimate for third-quarter total operating expenses suggests a more than 6% increase from the year-ago period, due to higher medical care costs and G&A expenses.
Stocks That Warrant a Look
While an earnings beat looks uncertain for Molina Healthcare, here are some companies from the broader Medical space that you may want to consider, as our model shows that these have the right combination of elements to post an earnings beat this time around:
Select Medical Holdings Corporation (SEM - Free Report) has an Earnings ESP of +8.58% and a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Select Medical’s bottom line for the to-be-reported quarter of 18 cents per share has witnessed one upward revision against no downward movement over the past week. The consensus mark for Select Medical’s revenues is pegged at $1.32 billion.
CVS Health Corporation (CVS - Free Report) has an Earnings ESP of +0.28% and a Zacks Rank of 2.
The Zacks Consensus Estimate for CVS Health’s bottom line for the to-be-reported quarter is pegged at $1.36, signaling 24.8% growth from a year ago. CVS Health’s earnings beat estimates in each of the past four quarters, with an average surprise of 22.6%.
Envista Holdings Corporation (NVST - Free Report) has an Earnings ESP of +4.26% and a Zacks Rank of 3.
The Zacks Consensus Estimate for Envista’s bottom line for the to-be-reported quarter indicates 125% year-over-year growth. Envista’s earnings beat estimates in each of the trailing four quarters, with an average surprise of 16.5%.